Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 105, Issue 4, 2001, Pages 332-342

  Perry, Rodney T ^a,d   Collins, Julianne S ^a   Harrell, Lindy E ^b   Acton, Ronald T ^c   Go, Rodney C P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b The University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d NONE   (United States)

Author keywords

APOE; Dementia; Ethnicity; Inflammation; TNF

Indexed keywords

APOLIPOPROTEIN E; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BASE PAIRING; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DNA; FEMALE; GENE FREQUENCY; GENES; GENOTYPE; HLA-A2 ANTIGEN; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; SOUTHEASTERN UNITED STATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035826546     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.1371     Document Type: Article

References (113)

1. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. Inflammation and Alzheimer's disease
3. The 5-repeat allele in the very-low-density lipoprotein receptor gene polymorphism is not increased in sporadic Alzheimer's disease in Japanese
4. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene
5. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene
6. A deletion in the angiotensin converting enzyme (ACE) gene is common among African Americans with essential hypertension
7. HLA A2 allele is associated with age at onset of Alzheimer's disease
8. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese
9. The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease
10. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein
11. Apolipoprotein E and Alzheimer disease: Genotype-specific risks by age and sex
12. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative
13. The genetics of Alzheimer disease: Current status and future prospects
14. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
15. TNF alpha plus IFN gamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs
16. Isolation of high molecular-weight DNA
17. Presenilin-1, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease
18. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
19. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
20. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E-receptor, in the central nervous system and in Alzheimer's disease
21. Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease
22. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer's disease
23. Searching for a chromosome 6 association with late onset Alzheimer disease
24. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: The NIMH Alzheimer disease genetics initiative
25. Association of the HLA-A2 allele with an earlier age of onset of Alzheimer's disease
26. Hypertension in blacks
27. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
28. No effect of the α1-antichymotrypsin A allele in Alzheimer's disease
29. α-2 Macroglobulin polymorphism and Alzheimer disease risk in the UK
30. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African Americans with hypertension
31. The angiotensin I-converting enzyme
32. No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample
33. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the aplipoprotein E gene in population-based and clinic samples
34. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis
35. Association between angiotensin-converting enzymne and Alzheimer disease
36. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
37. The epidemiology of cardiovascular disease in black Americans
38. Evidence for linkage to 6p21.3 in Alzheimer disease families containing APOE E4/E4 genotypes
39. 1-antichymotrypsin in Alzheimer disease
40. TNF-alpha gene polymorphism: Clinical and biological implications
41. 1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease
42. An in vitro model for the study of microglia-induced neurodegeneration: Involvement of nitric oxide and tumor necrosis factor-alpha
43. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans
44. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
45. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease
46. TNF-alpha promoter polymorphisms, production, and susceptibility to multiple sclerosis in different groups of patients
47. APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism
48. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene
49. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease
50. Interaction of apolipoprotein E ε4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: Problems facing the investigator
51. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease
52. A full genome scan for late onset Alzheimer's disease
53. LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation
54. Apolipoprotein and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies
55. Association at LRP gene locus with sporadic late-onset Alzheimer's disease
56. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population
57. Apolipoprotein E4 allele and Alzheimer disease: Examination of allelic association and effect on age at onset in both early- and late-onset cases
58. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
59. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks
60. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease
61. Neuroimmune mechanisms in Alzheimer disease pathogenesis
62. A simple salting out procedure for extracting DNA from nucleated cells
63. 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease
64. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis
65. Lack of association between α1-antichymotrypsin polymorphism, Alzheimer's disease, and allele ε4 of apolipoprotein E
66. α1-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease
67. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease
68. 1-antichymotrypsin polymorphism in Alzheimer's disease
69. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus
70. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease
71. Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease
72. Evidence of association of HLA-A2 allele with onset age of Alzheimer's disease
73. Complete genomic screen in late-onset familial Alzheimer disease: Evidence for a new locus on chromosome 12
74. Association of tumor necrosis factor (TNF) and class II major histocompatability complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells
75. Functional analysis of a new polymorphism in the human TNF alpha gene
76. Apolipoprotein E polymorphism and Alzheimer's disease
77. No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians
78. Apolipoprotein E in sporacic Alzheimer's disease: Allelic variation and receptor interactions
79. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein
80. Evidence for genetic admixture as a determinant of the occurrence of insulin-depentdent diabetes mellitus in U.S. blacks
81. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
82. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity
83. An α-2 macroglobulin insertion-deletion polymorphism in Alzheimer disease
84. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease
85. Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes
86. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population' is genotype dependent
87. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene
88. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
89. Further evidence linking late-onset Alzheimer disease with chromosome 12
90. Pathological immuno-reactions of glial cells in Alzheimer's disease and possible sites of interference
91. Translating cell biology into therapeutic advances in Alzheimer's disease
92. Binding of human apolipoprotein E to synthetic amyloid β-peptide: Isoform-specific effects and implications for late-onset Alzheimer disease
93. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease
94. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City
95. The APOE-ε4 allele and the risk of Alzheimer disease among African Americans, whites, and hispanics
96. Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome
97. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases
98. The -491 A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: Independent risk and linkage disequilibrium with the known APOE polymorphism
99. Apolipoprotein E: Risk factor for Alzheimer disease
100. Apolipoprotein ε4 allele in a population-based study of early-onset Alzheimer's disease
101. Strategy to sequence th 89 exons of the human LRP1 gene coding for the lipoprotein receptor related protein: Identification of one expressed mutation among 48 polymorphisms
102. Polymorphism at the TNF loci in rheumatoid arthritis
103. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease
104. Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease
105. Genetics of tumor necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases
106. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
107. Microglia as a unique cellular target in the treatment of stroke: Potential neurotoxic mediators produced by activated microglia
108. Roles of CNS macrophages in neurodegeneration
109. LRP gene and late-onset Alzheimer's disease
110. Distribution of apolipoprotein E gene polymorphisms in Japanese patients with Alzheimer's disease and in Japanese centenarians
111. α1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E ε4 allele carriers
112. A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution